Abstract
Background
An early and reliable prognostic indication in stroke patients is potentially useful for initiation of individual treatment and for informing patients and relatives. We recently developed a regression model as well as a simple 11-point predictive score (Essen ICH score) for functional recovery within three months after acute intracerebral hemorrhage (ICH) based on age and the National Institutes of Health Stroke Scale (NIH-SS). Here, we demonstrate the applicability of our models in an independent sample of ICH patients from controlled clinical trials.
Methods
The prognostic models were used to predict functional recovery in 564 patients from the Virtual International Stroke Trials Archive (VISTA). Furthermore, we tried to improve the accuracy by re-calibration and estimating new model parameters.
Findings
The logistic regression model and the Essen ICH score were able to correctly classify 77.5 % and 76.4 % of patients, respectively. Re-calibration and novel estimation of parameters yielded only a slight improvement of overall predictive accuracy.
Interpretation
For acute ICH patients included in controlled trials, our predictive models based on age and the NIH-SS correctly predict functional recovery after three months and could be useful for future trial design.
Article PDF
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
References
Broderick JP, Brott T, Tomsick T, Miller R, Huster G (1993) Intracerebral hemorrhage more than twice as common as subarachnoid hemorrhage. J Neurosurg 78(2):188–191
Weimar C, Weber C, Wagner M, Busse O, Haberl RL, Lauterbach KW, Diener HC (2003) Management patterns and health care use after intracerebral hemorrhage. A cost-of-illness study from a societal perspective in Germany. Cerebrovasc Dis 15:29–36
Dennis MS (2003) Outcome after brain haemorrhage. Cerebrovasc Dis 16 (Suppl 1):9–13
Weir CJ, Kaste M, Lees KR (2004) Targeting neuroprotection clinical trials to ischemic stroke patients with potential to benefit from therapy. Stroke 35(9):2111–2116
Young FB, Lees KR, Weir CJ (2005) Improving trial power through use of prognosis-adjusted end points. Stroke 36(3):597–601
Weimar C, Ho TW, Katsarava Z, Diener HC (2006) Improving patient selection for clinical acute stroke trials. Cerebrovasc Dis 21(5–6):386–392
König IR, Malley JD, Weimar C, Diener HC, Ziegler A (2007) Practical experiences on the necessity of external validation. Stat Med 26(30):5499–5511
Wyatt JC, Altman DG (1995) Commentary: Prognostic models: clinically useful or quickly forgotten? Br Med J 311(7019):1539–1541
Weimar C, Benemann J, Diener HC (2006) Development and validation of the Essen Intracerebral Haemorrhage Score. J Neurol Neurosurg Psychiatry 77(5):601–605
Weimar C, Roth M, Willig V, Kostopoulos P, Benemann J, Diener HC (2006) Development and validation of a prognostic model to predict recovery following intracerebral hemorrhage. J Neurol 253(6):788–793
Ali M, Bath PM, Curram J, Davis SM, Diener HC, Donnan GA, Fisher M, Gregson BA, Grotta J, Hacke W, Hennerici MG, Hommel M, Kaste M, Marler JR, Sacco RL, Teal P, Wahlgren NG, Warach S, Weir CJ, Lees KR (2007) The Virtual International Stroke Trials Archive. Stroke 38(6):1905–1910
Committee for Proprietary Medicinal Products (CPMP) (2000) Points to consider on clinical investigation of medicinal products for the treatment of acute stroke. The European Agency for the Evaluation of Medicinal Products. CPMP/EWP/560/98
Sacco RL, DeRosa JT, Haley EC Jr, Levin B, Ordronneau P, Phillips SJ, Rundek T, Snipes RG, Thompson JLP, for the GAIN Americas Investigators (2001) Glycine antagonist in neuroprotection for patients with acute stroke: GAIN Americas: a randomized controlled trial. Jama 285(13):1719–1728
Lees KR, Asplund K, Carolei A, Davis SM, Diener HC, Kaste M, Orgogozo JM, Whitehead J (2000) Glycine antagonist (gavestinel) in neuroprotection (GAIN International) in patients with acute stroke: a randomised controlled trial. GAIN International Investigators. Lancet 355(9219):1949–1954
Newcombe RG (1998) Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med 17:873–890
König IR, Ziegler A, Bluhmki E, Hacke W, Bath PMW, Sacco RL, Diener H-C, Weimar C (2008) Predicting long-term outcome after acute ischemic stroke – a simple index works in patients from controlled clinical trials. Stroke 39(6):1821–1826
Zhou XH, Qin GS (2005) A new confidence interval for the difference between two binomial proportions of paired data. J Statist Plann Inference 128:527–542
Ruiz-Sandoval JL, Chiquete E, Romero- Vargas S, Padilla-Martinez JJ, Gonzalez- Cornejo S (2007) Grading scale for prediction of outcome in primary intracerebral hemorrhages. Stroke 38(5):1641–1644
Hallevy C, Ifergane G, Kordysh E, Herishanu Y (2002) Spontaneous supratentorial intracerebral hemorrhage. Criteria for short-term functional outcome prediction. J Neurol 249(12):1704–1709
Schwarz S, Hafner K, Aschoff A, Schwab S (2000) Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology 54(2):354–361
Lisk DR, Pasteur W, Rhoades H, Putnam RD, Grotta JC (1994) Early presentation of hemispheric intracerebral hemorrhage: prediction of outcome and guidelines for treatment allocation. Neurology 44(1):133–139
Portenoy RK, Lipton RB, Berger AR, Lesser ML, Lantos G (1987) Intracerebral haemorrhage: a model for the prediction of outcome. J Neurol Neurosurg Psychiatry 50(8):976–979
Cheung RT, Zou LY (2003) Use of the original, modified, or new intracerebral hemorrhage score to predict mortality and morbidity after intracerebral hemorrhage. Stroke 34(7):1717–1722
Castellanos M, Leira R, Tejada J, Gil- Peralta A, Davalos A, Castillo J (2005) Predictors of good outcome in medium to large spontaneous supratentorial intracerebral haemorrhages. J Neurol Neurosurg Psychiatry 76(5):691–695
Rost NS, Smith EE, Chang Y, Snider RW, Chanderraj R, Schwab K, Fitz- Maurice E, Wendell L, Goldstein JN, Greenberg SM, Rosand J (2008) Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score. Stroke 39(8):2304–2309
Johnston KC, Wagner DP, Wang XQ, Newman GC, Thijs V, Sen S, Warach S (2007) Validation of an acute ischemic stroke model: does diffusion-weighted imaging lesion volume offer a clinically significant improvement in prediction of outcome? Stroke 38(6):1820–1825
Becker KJ, Baxter AB, Cohen WA, Bybee HM, Tirschwell DL, Newell DW, Winn HR, Longstreth WT Jr (2001) Withdrawal of support in intracerebral hemorrhage may lead to self-fulfilling prophecies. Neurology 56(6):766–772
Hemphill JC 3rd, Newman J, Zhao S, Johnston SC (2004) Hospital usage of early do-not-resuscitate orders and outcome after intracerebral hemorrhage. Stroke 35(5):1130–1134
Zahuranec DB, Brown DL, Lisabeth LD, Gonzales NR, Longwell PJ, Smith MA, Garcia NM, Morgenstern LB (2007) Early care limitations independently predict mortality after intracerebral hemorrhage. Neurology 68(20):1651–1657
Hemphill JC, Bonovich DC, Besmertis L, Manley GT, Johnston SC, Tuhrim S (2001) The ICH Score : A simple, reliable grading scale for intracerebral hemorrhage. Stroke 32(4):891–897
Jamora RD, Kishi-Generao EM Jr, Bitanga ES, Gan RN, Apaga NE, San Jose MC (2003) The ICH score: predicting mortality and functional outcome in an Asian population. Stroke 34(1):6–7; author reply 6–7
Fernandes H, Gregson BA, Siddique MS, Mendelow AD (2002) Testing the ICH score. Stroke 33(6):1455–1456; author reply 1455–1456
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
VISTA steering committee members: Lees KR (chair), Hacke W,Sacco RL, Diener HC, Grotta J, Lyden P, Donnan GA, Davis SM, BathPMW, Wahlgren NG, Hennerici M, Kaste M, Hommel M, Fisher M,Warach S, Curram J, Teal P, Gregson B, Marler J, Claesson L, BluhmkiE, K. Muir and A. Shuaib
Rights and permissions
About this article
Cite this article
Weimar, C., Ziegler, A., Sacco, R.L. et al. Predicting recovery after intracerebral hemorrhage – An external validation in patients from controlled clinical trials. J Neurol 256, 464–469 (2009). https://doi.org/10.1007/s00415-009-0115-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-009-0115-z